Can LLY reach $821?
$Eli Lilly(LLY)$ : This non-tech mega cap, that is part of the top 15 companies in the $S&P 500(.SPX)$ by market cap, has been hammered after the last earnings report, finding once again support at the $700 zone (November 2024, April 2025, and May 2025), which is the lower edge of the volume profile. The recent MACD crossover suggests this bounce has more fuel.
Right now the price is facing the 50 daily moving average in confluence with the upper Bollinger band. Some consolidation is possible but not guaranteed. LLY is in bullish mode considering its price above $732.6, the weekly central level provided last Friday, and after crossing the first bullish target $750.9, the price managed to close today right at the monthly central level $765.3, which is on confluence with $764.2, the next weekly level.
The price action during the last hours today presented a small retrace, not enough to set a shooting star, $750.9 can be now be the reference to manage risk for long positions and more risk aversion, otherwise the same central level $732.6 can continue as the reference for a line in the sand.
Monthly levels wise, this move can reach $821 if the resistance zone mentioned (50DMA, Bollinger and monthly+weekly level) is quickly overcome.
Image
For whom haven't open CBA can know more from below:
🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlimitedly!
Find out more here：
Trade on a Cash Boost Account and enjoy up to 6 months of Commission-Free trading.
💰Join the TB Contra Telegram Group to Get $10 Trading Vouchers Now🎉
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
